Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-03-24
1979-01-02
Robinson, Allen J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424319, A61K 31205, A61K 31195
Patent
active
041328035
ABSTRACT:
N-[3-(mercaptoacetylamino)benzoyl]glycine, alkali metal and amine salts thereof are potent topically effective mucolytic agents.
REFERENCES:
patent: 2520293 (1950-08-01), Weiss
patent: 3091569 (1963-05-01), Sheffner
patent: 3663690 (1972-05-01), Eichel et al.
patent: 3809697 (1974-05-01), Martin et al.
patent: 3857951 (1974-12-01), Buret
patent: 3950387 (1976-04-01), Joullie et al.
patent: 3971828 (1976-07-01), Mita et al.
patent: 4005222 (1977-01-01), Martin
patent: 4011240 (1977-03-01), Mauvernay et al.
Scheffner, New York Acad. Sci. 106, 298-310 (1963).
Carnahan Robert E.
Mead Johnson & Company
Robinson Allen J.
Uloth Robert H.
LandOfFree
Mercaptoacylamidobenzoylglycine mucolytic process and compositio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mercaptoacylamidobenzoylglycine mucolytic process and compositio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mercaptoacylamidobenzoylglycine mucolytic process and compositio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1518018